ATE92756T1 - Mittel zur behandlung von keratose. - Google Patents

Mittel zur behandlung von keratose.

Info

Publication number
ATE92756T1
ATE92756T1 AT88908350T AT88908350T ATE92756T1 AT E92756 T1 ATE92756 T1 AT E92756T1 AT 88908350 T AT88908350 T AT 88908350T AT 88908350 T AT88908350 T AT 88908350T AT E92756 T1 ATE92756 T1 AT E92756T1
Authority
AT
Austria
Prior art keywords
aqent
active component
injections
shogaol
keratosis
Prior art date
Application number
AT88908350T
Other languages
English (en)
Inventor
Katsuya Uda
Kenji Sakamoto
Mamoru Suekawa
Takeshi Yamamoto
Yuichiro Ohta
Keigo Chisaki
Masaki Aburada
Original Assignee
Tsumura & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP25077687A external-priority patent/JPH0228567B2/ja
Priority claimed from JP63028721A external-priority patent/JPH01207256A/ja
Application filed by Tsumura & Co filed Critical Tsumura & Co
Application granted granted Critical
Publication of ATE92756T1 publication Critical patent/ATE92756T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88908350T 1987-10-06 1988-09-22 Mittel zur behandlung von keratose. ATE92756T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP25077687A JPH0228567B2 (ja) 1987-10-06 1987-10-06 Katsukashochiryozai
JP63028721A JPH01207256A (ja) 1988-02-12 1988-02-12 新規なシス‐（６）‐シヨウガオールおよび該化合物を有効成分とする角化症治療剤
PCT/JP1988/000959 WO1989003376A1 (fr) 1987-10-06 1988-09-22 Agent de traitement de la keratose
EP88908350A EP0334967B1 (de) 1987-10-06 1988-09-22 Mittel zur behandlung von keratose

Publications (1)

Publication Number Publication Date
ATE92756T1 true ATE92756T1 (de) 1993-08-15

Family

ID=26366870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88908350T ATE92756T1 (de) 1987-10-06 1988-09-22 Mittel zur behandlung von keratose.

Country Status (5)

Country Link
EP (1) EP0334967B1 (de)
KR (1) KR920000892B1 (de)
AT (1) ATE92756T1 (de)
DE (1) DE3883208T2 (de)
WO (1) WO1989003376A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507712A (ja) * 1997-01-09 2001-06-12 ソシエテ デチュード エ ドュ ルシェルシュ アン ファルマコニョジ−エスアエルペ 脱臭組成物の製造におけるショーガオール類およびギンゲロール類の使用
FR2758086B1 (fr) * 1997-01-09 1999-02-26 Daniel Jean Shogaols pour l'utilisation comme medicaments, produits cosmetiques et produits dietetiques, procede d'obtention desdits shogaols et extraits vegetaux les contenant
FR2950804B1 (fr) * 2009-10-01 2011-12-23 Oreal Composition, utilisation et procede de conservation
FR2951079B1 (fr) * 2009-10-08 2012-04-20 Oreal Composition photoprotectrice a base d'un compose 2-alcoxy-4-alkylcetone phenol ; utilisation dudit compose pour augmenter le facteur de protection solaire
FR2973227B1 (fr) * 2011-04-01 2014-08-08 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
FR2973230B1 (fr) * 2011-04-01 2013-11-01 Oreal Utilisation de gingerone ou de ses derives pour diminuer ou retarder les signes du vieillissement de la peau
FR2973228B1 (fr) * 2011-04-01 2014-08-01 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
KR101582188B1 (ko) * 2014-01-20 2016-01-04 한국식품연구원 칸디다 유틸리스를 이용하여 파라돌 함량을 증가시키는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61134338A (ja) * 1984-12-03 1986-06-21 Wako Pure Chem Ind Ltd フエノ−ルケトン化合物の製造法
JPS61137834A (ja) * 1984-12-06 1986-06-25 Wako Pure Chem Ind Ltd 新規フェノールケトン誘導体
JPS61191625A (ja) * 1985-02-19 1986-08-26 Shozo Yanagida 半導体を光触媒とするシス−トランス異性化法
JP2975194B2 (ja) * 1991-11-06 1999-11-10 浜松ホトニクス株式会社 半導体デバイス検査システム
JPH0684231A (ja) * 1992-08-31 1994-03-25 Manatake Fujii 情報伝送によるテレビジョン番組録画予約システム

Also Published As

Publication number Publication date
EP0334967A4 (en) 1991-11-27
EP0334967A1 (de) 1989-10-04
KR920000892B1 (ko) 1992-01-30
EP0334967B1 (de) 1993-08-11
DE3883208D1 (de) 1993-09-16
WO1989003376A1 (fr) 1989-04-20
KR890701526A (ko) 1989-12-20
DE3883208T2 (de) 1993-12-23

Similar Documents

Publication Publication Date Title
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
UA41502C2 (uk) Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
CA2069961A1 (en) Method and compositions for inhibition of disorders associated with oxidative damage
KR920000324A (ko) 필수 지방산 처리법
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
KR970061244A (ko) 치매 치료용 약학 조성물
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
KR950007848A (ko) (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법
KR930005619A (ko) 위장 질환 치료용 약제
ATE74006T1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
ATE92756T1 (de) Mittel zur behandlung von keratose.
KR890004705A (ko) 항바이러스성 제제
KR920702225A (ko) 약학 조성물
KR940013503A (ko) 동맥경화증의 예방 또는 치료용 약제학적 조성물
ES2062763T3 (es) Preparacion farmaceutica de 1-octadecil-2-metil-glicero-3-fosfocolina administrable por via intravenosa.
DE3775854D1 (de) Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.
KR880004810A (ko) 소화성 궤양 치료제
DE3783122D1 (de) Verwendung von rekombiniertem menschlichem alpha-interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
Gjessing et al. Intramuscular injection of procaine penicillin combined with oral administration of ampicillin in the treatment of gonorrhoea
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
DE69211743D1 (de) Aureobasidin enthaltendes Arzneimittel
GB1327465A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee